Plus   Neg

Stock Alert: Under Armour Slips 4%

Shares of footwear, sports, and casual apparel maker Under Armour, Inc. (UA) are falling more than 4% Friday morning after the company said it expects Covid-19 to impact its business for the remainder of the year.

Under Armour estimates traffic trends to remain lower for the second half of this year.

However, the company's second-quarter results were better-than-expected. Loss per share on an adjusted basis of $0.31 per share beat the Street estimate for $0.41 loss per share.

Revenue was down 41 per cent to $708 million impacted by COVID-19-induced store closures. The consensus estimate was at $558.52 million.

Under Armour stock is currently trading at $9.77. It has been trading in the range of $6.37- $20.44 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030. The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020.
Follow RTT